213 related articles for article (PubMed ID: 24529931)
1. Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study.
Bourantas CV; Papafaklis MI; Kotsia A; Farooq V; Muramatsu T; Gomez-Lara J; Zhang YJ; Iqbal J; Kalatzis FG; Naka KK; Fotiadis DI; Dorange C; Wang J; Rapoza R; Garcia-Garcia HM; Onuma Y; Michalis LK; Serruys PW
JACC Cardiovasc Interv; 2014 Mar; 7(3):315-24. PubMed ID: 24529931
[TBL] [Abstract][Full Text] [Related]
2. Fusion of optical coherence tomographic and angiographic data for more accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation: comparison with intravascular ultrasound-derived reconstructions.
Bourantas CV; Papafaklis MI; Lakkas L; Sakellarios A; Onuma Y; Zhang YJ; Muramatsu T; Diletti R; Bizopoulos P; Kalatzis F; Naka KK; Fotiadis DI; Wang J; Garcia Garcia HM; Kimura T; Michalis LK; Serruys PW
Int J Cardiovasc Imaging; 2014 Mar; 30(3):485-94. PubMed ID: 24458955
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model.
Tenekecioglu E; Torii R; Bourantas C; Abdelghani M; Cavalcante R; Sotomi Y; Crake T; Su S; Santoso T; Onuma Y; Serruys PW
Int J Cardiol; 2017 Jan; 227():467-473. PubMed ID: 27839816
[TBL] [Abstract][Full Text] [Related]
5. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
[TBL] [Abstract][Full Text] [Related]
6. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
[No Abstract] [Full Text] [Related]
7. Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial.
Bourantas CV; Farooq V; Zhang Y; Muramatsu T; Gogas BD; Thuesen L; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Dorange C; Rapoza R; Onuma Y; Garcia-Garcia HM; Serruys PW
EuroIntervention; 2015 Mar; 10(11):1299-306. PubMed ID: 24769420
[TBL] [Abstract][Full Text] [Related]
8. Impact of local endothelial shear stress on neointima and plaque following stent implantation in patients with ST-elevation myocardial infarction: A subgroup-analysis of the COMFORTABLE AMI-IBIS 4 trial.
Bourantas CV; Räber L; Zaugg S; Sakellarios A; Taniwaki M; Heg D; Moschovitis A; Radu M; Papafaklis MI; Kalatzis F; Naka KK; Fotiadis DI; Michalis LK; Serruys PW; Garcia Garcia HM; Windecker S
Int J Cardiol; 2015; 186():178-85. PubMed ID: 25828109
[TBL] [Abstract][Full Text] [Related]
9. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Intracoronary Structural and Vasomotor Assessment of the ABSORB Bioresorbable Vascular Scaffold.
Altisent OA; Goncalves-Ramírez LR; Fernández L; Viladés D; Gutiérrez E; Mitomo S; Latib A; Córdoba-Soriano JG; Adeliño R; Amat-Santos I; Muñoz JF; Elízaga J; Bezzera H; Pereira GTR; de Prado AP; Carrillo X; Fernández-Nofrerias E; Vilalta V; Rodríguez-Leor O; Llibre C; Fadeuilhe E; Trujillo A; Mauri J; de la Torre Hernández JM; Bayes-Genís A; Puri R
Am J Cardiol; 2022 Apr; 168():55-63. PubMed ID: 35058053
[TBL] [Abstract][Full Text] [Related]
11. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.
Gutiérrez-Chico JL; Gijsen F; Regar E; Wentzel J; de Bruyne B; Thuesen L; Ormiston J; McClean DR; Windecker S; Chevalier B; Dudek D; Whitbourn R; Brugaletta S; Onuma Y; Serruys PW
JACC Cardiovasc Interv; 2012 Apr; 5(4):428-35. PubMed ID: 22516401
[TBL] [Abstract][Full Text] [Related]
12. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
13. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold.
Koltowski L; Tomaniak M; Ochijewicz D; Zieliński K; Proniewska K; Malinowski KP; Zaleska M; Maksym J; Roleder T; Partyka L; Kochman W; Filipiak KJ; Opolski G; Kochman J
Am J Cardiol; 2021 Sep; 155():23-31. PubMed ID: 34315572
[TBL] [Abstract][Full Text] [Related]
14. In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis.
Sheehy A; Gutiérrez-Chico JL; Diletti R; Oberhauser JP; Glauser T; Harrington J; Kossuth MB; Rapoza RJ; Onuma Y; Serruys PW
EuroIntervention; 2012 Feb; 7(10):1227-35. PubMed ID: 22222916
[TBL] [Abstract][Full Text] [Related]
15. Comparison of endothelial shear stress between ultrathin strut bioresorbable polymer drug-eluting stent vs durable-polymer drug-eluting stent post-stent implantation: An optical coherence tomography substudy from BIOFLOW II.
Beyene S; Tufaro V; Garg M; Gkargkoulas F; Calderon AT; Safi H; Waksman R; Windecker S; Torii R; Melaku GD; Bulant CA; Bourantas CV; Blanco PJ; Garcia-Garcia HM
Cardiovasc Revasc Med; 2024 Apr; 61():26-34. PubMed ID: 38042738
[TBL] [Abstract][Full Text] [Related]
16. Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study.
Lhermusier T; Ohayon P; Boudou N; Bouisset F; Campelo-Parada F; Roncalli J; Elbaz M; Carrié D
Trials; 2019 Apr; 20(1):210. PubMed ID: 30975219
[TBL] [Abstract][Full Text] [Related]
17. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
[TBL] [Abstract][Full Text] [Related]
18. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
19. Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study.
Zhang YJ; Iqbal J; Nakatani S; Bourantas CV; Campos CM; Ishibashi Y; Cho YK; Veldhof S; Wang J; Onuma Y; Garcia-Garcia HM; Dudek D; van Geuns RJ; Serruys PW;
JACC Cardiovasc Interv; 2014 Dec; 7(12):1361-9. PubMed ID: 25457053
[TBL] [Abstract][Full Text] [Related]
20. Neoatherosclerosis 5 Years After Bioresorbable Vascular Scaffold Implantation.
Moriyama N; Shishido K; Tanaka Y; Yokota S; Hayashi T; Miyashita H; Koike T; Yokoyama H; Takada T; Nishimoto T; Ochiai T; Tobita K; Yamanaka F; Mizuno S; Murakami M; Takahashi S; Saito S
J Am Coll Cardiol; 2018 May; 71(17):1882-1893. PubMed ID: 29699614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
